Chronic obstructive pulmonary disease (COPD) affects approximately 26 million people in the United States. It is estimated that 16%-56% of these people have bronchiectasis (pathologic dilation of the airways). The presence of bronchiectasis in COPD has been linked to longer hospital stays, prolonged recovery from exacerbations, and increased mortality. The visual assessment of bronchiectasis on high-resolution computed tomography (CT) scans is the standard diagnostic method. In this investigation the visual assessment will be used to further develop, validate, refine, and apply an automated imaging tool to objectively assess the burden of bronchiectasis in smokers using baseline and follow-up chest CT scans from the COPDGene Study (a large cohort of smokers with and without COPD).
In Aim 1, we will perform a visual scoring and marking of bronchiectasis on a subset of baseline and 5-yr follow- up CT scans. We will then assess the associations between baseline bronchiectasis and acute respiratory disease episodes, health-related quality of life, and death.
In aim 2, we will perform point-based (at a single slice) objective measurements of bronchial dilation and airway morphology in bronchiectatic and non- bronchiectatic airway sections labeled for Aim 1 to identify CT features that distinguish bronchiectasis. We will build receiver operating characteristics (ROC) curves to determine the predictive ability of these objective measurements to detect bronchiectasis. Finally, in Aim 3 we will fully develop, validate, and refine an automated imaging tool with the features found to be discriminatory to detect bronchiectasis in Aims 1 and 2. We will then determine the burden of bronchiectasis using this tool on all baseline and follow-up CT scans (estimated N= 16,300) and assess its association with clinically relevant disease outcomes including acute respiratory disease episodes, quality of life, and mortality. We will also use ROC analysis as well as the integrated discrimination index (IDI) and net reclassification index (NRI) measures to assess the contribution of our imaging tool to predict those outcomes.
Bronchiectasis is permanent, abnormal airway enlargement and is common in chronic obstructive pulmonary disease (COPD), a smoking-related lung disease. In this proposal we will develop, validate, and apply an imaging tool to detect and quantify bronchiectasis in a large group of smokers with and without COPD. We will then assess the associations between bronchiectasis and relevant measures of this disease including acute respiratory disease episodes (worsening shortness of breath, cough, or phlegm production), quality of life, and death.
|Burkart, Kristin M; Sofer, Tamar; London, Stephanie J et al. (2018) A Genome-Wide Association Study in Hispanics/Latinos Identifies Novel Signals for Lung Function. The Hispanic Community Health Study/Study of Latinos. Am J Respir Crit Care Med 198:208-219|
|Copeland, Carla R; Nath, Hrudaya; Terry, Nina L J et al. (2018) Paratracheal Paraseptal Emphysema and Expiratory Central Airway Collapse in Smokers. Ann Am Thorac Soc 15:479-484|
|Diaz, Alejandro A; Maselli, Diego J; Rahaghi, Farbod et al. (2018) Pulmonary vascular pruning in smokers with bronchiectasis. ERJ Open Res 4:|
|Díaz, Alejandro A (2018) The Case of Missing Airways in Chronic Obstructive Pulmonary Disease. Am J Respir Crit Care Med 197:4-6|
|Díaz, Alejandro A; Celli, Bartolomé; Celedón, Juan C (2018) Chronic Obstructive Pulmonary Disease in Hispanics. A 9-Year Update. Am J Respir Crit Care Med 197:15-21|